Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Frontiers in Cardiovascular Medicine
|
November 13, 2024
Bibliometric analysis of imaging and treatment strategies for severe tricuspid regurgitation from 2015 to 2023
Johannes Schlegl, Marwin Bannehr, Tanja Kücken, et al.
Biomarkers in Medicine
|
February 17, 2026
Next-generation biomarkers for short term risk stratification in tricuspid valve intervention
Christoph Edlinger, Johannes Schlegl, Marwin Bannehr, et al.
Wiener Klinische Wochenschrift
|
January 14, 2026
Combining MELD-XI score and hemodynamic parameters enhances short-term prognostic value in patients undergoing transcatheter tricuspid valve interventions
Johannes Schlegl, Marwin Bannehr, Tanja Kücken, et al.
Annals of Cardiothoracic Surgery
|
June 15, 2026
Comparative prognostic performance of risk scores for 12-month mortality and rehospitalization after transcatheter tricuspid valve intervention
Johannes Schlegl, Christoph Edlinger, Marwin Bannehr, et al.
Journal of Clinical Medicine
|
January 1, 2020
Preoperative Ascorbic Acid Levels in Proximal Femur Fracture Patients Have No Postoperative Clinical Impact, While Ascorbic Acid Levels upon Discharge Have a Major Effect on Postoperative Outcome
Katharina Hill-Mündel, Johannes Schlegl, Hans Konrad Biesalski, et al.
Biomarkers in Medicine
|
July 3, 2026
Serial sST2 dynamics after transcatheter tricuspid valve intervention: a candidate biomarker of biological response
Christoph Edlinger, Johannes Schlegl, Marwin Bannehr, et al.
Journal of Cardiovascular Development and Disease
|
June 25, 2026
Prognostic Performance of a Modified TRI-SCORE Incorporating RV-PA Uncoupling After Transcatheter Tricuspid Valve Interventions
Mhd Nawar Alachkar, Johannes Schlegl, Marwin Bannehr, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Frontiers in Cardiovascular Medicine
|
November 13, 2024
Bibliometric analysis of imaging and treatment strategies for severe tricuspid regurgitation from 2015 to 2023
Johannes Schlegl, Marwin Bannehr, Tanja Kücken, et al.
Biomarkers in Medicine
|
February 17, 2026
Next-generation biomarkers for short term risk stratification in tricuspid valve intervention
Christoph Edlinger, Johannes Schlegl, Marwin Bannehr, et al.
Wiener Klinische Wochenschrift
|
January 14, 2026
Combining MELD-XI score and hemodynamic parameters enhances short-term prognostic value in patients undergoing transcatheter tricuspid valve interventions
Johannes Schlegl, Marwin Bannehr, Tanja Kücken, et al.
Annals of Cardiothoracic Surgery
|
June 15, 2026
Comparative prognostic performance of risk scores for 12-month mortality and rehospitalization after transcatheter tricuspid valve intervention
Johannes Schlegl, Christoph Edlinger, Marwin Bannehr, et al.
Journal of Clinical Medicine
|
January 1, 2020
Preoperative Ascorbic Acid Levels in Proximal Femur Fracture Patients Have No Postoperative Clinical Impact, While Ascorbic Acid Levels upon Discharge Have a Major Effect on Postoperative Outcome
Katharina Hill-Mündel, Johannes Schlegl, Hans Konrad Biesalski, et al.
Biomarkers in Medicine
|
July 3, 2026
Serial sST2 dynamics after transcatheter tricuspid valve intervention: a candidate biomarker of biological response
Christoph Edlinger, Johannes Schlegl, Marwin Bannehr, et al.
Journal of Cardiovascular Development and Disease
|
June 25, 2026
Prognostic Performance of a Modified TRI-SCORE Incorporating RV-PA Uncoupling After Transcatheter Tricuspid Valve Interventions
Mhd Nawar Alachkar, Johannes Schlegl, Marwin Bannehr, et al.
Page
of 1